Acclarent, INC
Reporting payments is a legal requirement; large totals often reflect large product portfolios.
$2.6Mgeneral payments (2019-2025)
$4,000research payments (2019-2025)
4,968clinicians paid
General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.
General payments by year
General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.
Products most associated with its payments
- Acclarent Balloon Inflation Device $183K associated (2023-2025)
- Trudi Nav Cable $135K associated (2023-2025)
- Acclarent Aera $72K associated (2023-2025)
- Trudi Nav Suction $69K associated (2023-2025)
- Relieva Spinplus $35K associated (2023-2025)
- Acclarent Navwire $31K associated (2023-2025)
- Acclarent Se Inflation Device $4,827 associated (2023-2025)
- Relieva Tract $3,236 associated (2023-2025)
- Spine & Trauma 3d Navigation $2,107 associated (2023-2025)
- Relieva Ultirra $1,551 associated (2023-2025)
- Inspira Air $791 associated (2023-2025)
- Relieva Scout $432 associated (2023-2025)
Specialties it works with most
Clinicians with the largest reported totals
Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.
| Clinician | Location | Specialty | General payments (2019-2025) |
|---|---|---|---|
| Marc Dean | Fort Worth, TX | Otolaryngology | $352,860.01 |
| Raymond Weiss | Ocean Springs, MS | $161,016.92 | |
| Raj Sindwani | Cleveland, OH | Otolaryngology | $122,311.87 |
| Dennis Poe | Boston, MA | Otolaryngology | $116,955.21 |
| Troy Woodard | Cleveland, OH | Otolaryngology | $116,618.27 |
| Adam Zanation | Hickory, NC | Otolaryngology | $96,985.58 |
| Karen Hoffmann | Atlanta, GA | Otolaryngology | $84,855.10 |
| Martin Citardi | Houston, TX | Otolaryngology | $77,515.28 |
| Brian Weeks | San Diego, CA | Otolaryngology | $58,895.15 |
| Nithin Adappa | Philadelphia, PA | Otolaryngology | $56,624.12 |
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.